Kiniksa Pharmaceuticals, Ltd. Financial Ratios — KNSA Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-124.8	-55.88	-56.16	-53.44	-54.24	52.96	2.86	-7.8	8.78
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	10
Gross Margin (%)	- -	- -	- -	- -	- -	76.39	89.6	87.64	85.61	54.66
EBITDA Margin (%)	- -	- -	- -	- -	- -	-400.27	5.53	-8.46	-10.38	11.63
Operating Margin (%)	- -	- -	- -	- -	- -	-406.38	4.44	-9.32	-10.78	11.4
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	91.62	- -	- -	48.3
Pretax Margin (%)	- -	- -	- -	- -	- -	-406.13	5.01	-6.16	-8.54	13.12
Profit Margin (%)	- -	- -	- -	- -	- -	-409.72	83.28	5.21	-10.21	8.71
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	-409.72	83.28	5.21	-10.21	8.71
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	33.6
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	3	7	6	6	12	10	9
ST Debt	- -	- -	- -	2	2	3	3	2	2	3
LT Debt	- -	- -	- -	1	5	3	3	10	8	7
Total Debt/EBITDA	- -	- -	- -	-0.02	-0.05	-0.04	0.49	-0.54	-0.22	0.12
Net Debt/EBITDA	2.33	0.7	0.67	0.28	0.74	0.79	-10.08	4.72	4.18	-2.1
Total Debt/EBIT	- -	- -	- -	-0.02	-0.04	-0.04	0.61	-0.49	-0.22	0.12
Net Debt/EBIT	2.33	0.7	0.67	0.28	0.72	0.78	-12.56	4.28	4.02	-2.14
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-46.26	-191.6	-60.32	-139.89	-148.07	-290.11	-107.04	-90.81	-89.76	-60.52
Long-Term Debt/Equity (%)	- -	- -	- -	0.42	1.56	1.44	0.66	2.28	1.79	1.15
Long-Term Debt/Capital (%)	- -	- -	- -	-0.27	-0.96	-0.4	-0.54	-2.15	-1.54	-1.44
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.38	1.4	1.15	0.57	1.9	1.35	0.85
Total Debt/Equity (%)	- -	- -	- -	1.18	2.24	3.27	1.49	2.79	2.25	1.67
Total Debt/Capital (%)	- -	- -	- -	-0.75	-1.37	-0.9	-1.22	-2.63	-1.93	-2.1
Total Debt/Total Assets (%)	- -	- -	- -	1.04	2	2.6	1.29	2.33	1.7	1.24
Net Debt to Equity	217.51	50.78	-25.77	-20.82	-36.56	-66.19	-30.98	-24.6	-41.87	-29.17
Net Debt/Capital (%)	68.18	33.36	27.04	11.72	18.26	15.47	20.16	18.82	26.42	26.79
EBITDA	-24	-65	-108	-168	-155	-154	12	-23	-44	79
EBITDA-CapEx	-24	-65	-113	-171	-155	-175	12	-23	-44	77
Operating Income (Loss)	-24	-65	-108	-170	-157	-157	10	-25	-46	77

Liquidity (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	24.31	2.61	7.22	8.39	10.16	4.06	4.05	3.24	2.42	2.98
Current Ratio	24.47	2.7	7.37	8.68	10.46	4.38	5.16	4.34	3.3	3.79
Quick Ratio	24.31	2.61	7.22	8.39	10.16	4.15	4.48	3.58	2.84	3.09
CFO/Avg Current Liab	- -	-5.09	-2.7	-4.5	-4.58	-3.29	0.13	0.24	0.31	1.15
Common Equity/Total Assets	-46.26	-191.6	-60.32	-139.89	-148.07	-290.11	-107.04	-90.81	-89.76	-60.52
Long-Term Debt/Equity (%)	- -	- -	- -	0.42	1.56	1.44	0.66	2.28	1.79	1.15
Long-Term Debt/Capital (%)	- -	- -	- -	-0.27	-0.96	-0.4	-0.54	-2.15	-1.54	-1.44
Long-Term Debt/Total Assets (%)	- -	- -	- -	0.38	1.4	1.15	0.57	1.9	1.35	0.85
Total Debt/Equity (%)	- -	- -	- -	1.18	2.24	3.27	1.49	2.79	2.25	1.67
Total Debt/Capital (%)	- -	- -	- -	-0.75	-1.37	-0.9	-1.22	-2.63	-1.93	-2.1
Total Debt/Total Assets (%)	- -	- -	- -	1.04	2	2.6	1.29	2.33	1.7	1.24
CFO/Total Liabilities	-26.6	-36.6	-189.73	-544.02	-363.8	-264.43	9.14	15.2	18.08	70.39
CFO/CapEx	-7,289	-727.81	-15.31	-49.44	-482.45	-6.19	55.3	102.32	92.74	88
Altman's Z-Score	-0.9	-6.48	10.72	9.17	14.95	4.32	9.36	7.98	5.65	10.37

Working Capital (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	19.34	26.46	15.93	13.44	23.64
Days Sales Outstanding	- -	- -	- -	- -	- -	18.87	13.8	22.91	27.16	15.44
Inventory Turnover	- -	- -	- -	- -	- -	4.95	1.81	1.27	2.12	7.56
Days Inventory Outstanding	- -	- -	- -	- -	- -	73.7	201.46	288.01	172.24	48.27
Accounts Payable Turnover	- -	- -	- -	- -	- -	10.78	8.36	5.32	10.92	165.11
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	33.87	43.67	68.63	33.43	2.21
Cash Conversion Cycle	- -	- -	- -	- -	- -	58.7	171.59	242.29	165.97	61.5
Inventory to Cash Days	- -	- -	- -	- -	- -	-54.83	-187.67	-265.1	-145.08	-32.83
Inventories	- -	- -	- -	- -	- -	4	22	31	26	55
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	10	10
Work In Process	- -	- -	- -	- -	- -	- -	6	18	- -	29
Finished Goods	- -	- -	- -	- -	- -	4	15	13	21	21
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	830	598	1,093	807	1,039	1,229	1,413	3,061
- Cash & Cash Equivalents	56	46	72	47	114	122	123	108	184	166
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	3	7	6	6	12	10	9
Enterprise Value	-56	-46	523	367	776	631	855	1,035	1,179	2,656
Total Capital	-26	-91	-194	-353	-510	-669	-486	-466	-511	-453
Total Debt/Capital (%)	- -	- -	- -	-0.75	-1.37	-0.9	-1.22	-2.63	-1.93	-2.1
Total Debt / EV	- -	- -	- -	0.01	0.01	0.01	0.01	0.01	0.01	- -
EV/Sales	- -	- -	- -	- -	- -	16.37	3.88	3.83	2.79	3.92
EV/EBITDA	- -	- -	- -	- -	- -	- -	70.2	- -	- -	33.72
EV/EBIT	- -	- -	- -	- -	- -	- -	87.45	- -	- -	34.4
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	147.18	77.79	45.9	19.25
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	144.56	77.04	45.41	19.03
Diluted Market Cap	- -	- -	830	598	1,093	807	1,055	1,262	1,413	3,258
Diluted Enterprise Value	-56	-46	758	554	986	691	938	1,166	1,239	3,102
EV per Share	- -	- -	17.69	6.79	12.55	9.2	12.32	14.77	16.51	35.8
TTM Sales	- -	- -	- -	- -	- -	39	220	270	423	678
TTM EBITDA	-24	-65	-108	-168	-155	-154	12	-23	-44	79
TTM Operating Income	-24	-65	-108	-170	-157	-157	10	-25	-46	77
TTM Cash Flow to Firm	-22	-50	-81	-158	-137	-126	6	13	26	138
TTM Free Cash Flow to Firm	-22	-50	-76	-155	-136	-106	6	13	26	140

Multiples (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-10.96	-3.85	-8.02	-7.62	178.44	93.93	54.41	23.35
EV/EBIT	- -	- -	- -	- -	- -	- -	87.45	- -	- -	34.4
Enterprise Value	-56	-46	523	367	776	631	855	1,035	1,179	2,656
Low Price	- -	- -	13.04	5.01	10.3	10.3	7.36	10.29	16.56	17.82
EV/Sales	- -	- -	- -	- -	- -	16.37	3.88	3.83	2.79	3.92
EV/EBITDA	- -	- -	- -	- -	- -	- -	70.2	- -	- -	33.72
Price/Earnings	- -	- -	- -	- -	- -	- -	5.67	87.25	- -	51.87
Price/Earnings Average	- -	- -	-5.67	-4.53	-6.99	-6.59	4.34	74.49	-35.38	37.52
Price/Earnings High	- -	- -	-9.41	-9.49	-10.99	-10.73	6.51	102.72	-46.55	55.86
Price/Earnings Low	- -	- -	-3.73	-1.67	-3.95	-4.47	2.78	51.19	-27.38	22.41
Price/Book Value	- -	- -	-4.27	-1.68	-2.11	-1.2	-2.11	-2.57	-2.71	-6.62
Price/Book Value Average	- -	- -	-3.01	-2.06	-2.18	-1.54	-1.62	-2.19	-2.93	-4.79
Price/Book Value High	- -	- -	-5	-4.32	-3.43	-2.51	-2.42	-3.03	-3.86	-7.13
Price/Book Value Low	- -	- -	-1.98	-0.76	-1.23	-1.05	-1.04	-1.51	-2.27	-2.86
Price/Tangible Book Value	- -	- -	2.97	2.65	3.5	4.87	2.75	2.91	3.35	5.54
Price/Tangible Book Value Average	- -	- -	2.1	3.25	3.61	6.28	2.11	2.49	3.62	4.01
Price/Tangible Book Value High	- -	- -	3.48	6.82	5.68	10.22	3.16	3.43	4.76	5.97
Price/Tangible Book Value Low	- -	- -	1.38	1.2	2.04	4.26	1.35	1.71	2.8	2.39
Price/Sales	- -	- -	- -	- -	- -	20.94	4.72	4.55	3.34	4.52
Price/Sales Average	- -	- -	- -	- -	- -	27	3.62	3.88	3.61	3.27
Price/Sales High	- -	- -	- -	- -	- -	43.95	5.42	5.35	4.75	4.86
Price/Sales Low	- -	- -	- -	- -	- -	18.33	2.32	2.67	2.79	1.95
Price/Cash Flow	- -	- -	-10.25	-3.77	-8	-6.39	178.98	92.39	55	22.18
Price/Cash Flow Average	- -	- -	-7.22	-4.63	-8.26	-8.24	137.18	78.87	59.48	16.04
Price/Cash Flow High	- -	- -	-11.99	-9.7	-12.99	-13.41	205.45	108.77	78.27	23.89
Price/Cash Flow Low	- -	- -	-4.76	-1.71	-4.67	-5.59	87.94	54.2	46.04	9.58
Price/Free Cash Flow Average	- -	- -	-7.73	-4.73	-8.27	-9.83	136.76	80.18	58.85	16.88
Price/Free Cash Flow High	- -	- -	-12.83	-9.9	-13.01	-16	204.82	110.58	77.43	25.14
Price/Free Cash Flow Low	- -	- -	-5.09	-1.75	-4.68	-6.67	87.67	55.1	45.55	10.09
EV/Sales Average	- -	- -	- -	- -	- -	23.98	3.09	3.53	3.2	3.04
EV/Sales High	- -	- -	- -	- -	- -	40.93	4.89	5	4.34	4.63
EV/Sales Low	- -	- -	- -	- -	- -	15.31	1.79	2.31	2.38	1.72
EV/EBITDA Average	2.33	0.7	-4.76	-4.1	-6.58	-5.99	55.84	-41.71	-30.84	26.12
EV/EBITDA High	2.33	0.7	-8.34	-8.89	-10.75	-10.22	88.4	-59.11	-41.82	39.86
EV/EBITDA Low	2.33	0.7	-2.9	-1.35	-3.42	-3.82	32.35	-27.36	-22.97	14.8
EV/EBIT Average	2.33	0.7	-4.74	-4.05	-6.48	-5.9	69.56	-37.84	-29.69	26.64
EV/EBIT High	2.33	0.7	-8.32	-8.78	-10.59	-10.07	110.12	-53.62	-40.27	40.66
EV/EBIT Low	2.33	0.7	-2.9	-1.33	-3.37	-3.77	40.3	-24.81	-22.12	15.1
Last Price	- -	- -	28.09	11.06	17.67	11.77	14.98	17.54	19.78	41.25
High Price	- -	- -	32.88	28.43	28.67	24.7	17.2	20.65	28.15	44.42
Enterprise Value Average	-56	-46	513	689	1,020	924	680	953	1,354	2,058
Enterprise Value High	-56	-46	900	1,492	1,666	1,577	1,076	1,351	1,837	3,140
Enterprise Value Low	-56	-46	313	227	530	590	394	625	1,009	1,166

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	47	47	49	55	68	69	70	70	73	76
Diluted Weighted Avg Shares	32	32	30	54	62	69	70	72	71	79
Basic Weighted Avg Shares	32	32	30	54	62	69	69	70	71	74
Revenue per Share	- -	- -	- -	- -	- -	0.56	3.17	3.86	5.93	9.13
EBITDA per Share	-0.74	-2.01	-3.65	-3.11	-2.51	-2.25	0.18	-0.33	-0.61	1.06
Operating Income per Share	-0.74	-2.01	-3.66	-3.14	-2.54	-2.28	0.14	-0.36	-0.64	1.04
Basic EPS, GAAP	-0.74	-2	-3.49	-2.99	-2.61	-2.3	2.64	0.2	-0.6	0.8
Basic EPS from Cont Ops	-0.74	-2	-3.49	-2.99	-2.61	-2.3	2.64	0.2	-0.6	0.8
Diluted EPS, GAAP	-0.74	-2	-3.49	-2.99	-2.61	-2.3	2.6	0.2	-0.6	0.75
Diluted EPS from Cont Ops	-0.74	-2	-3.49	-2.99	-2.61	-2.3	2.6	0.2	-0.6	0.75
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.67	-1.55	-2.74	-2.93	-2.21	-1.84	0.08	0.19	0.36	1.86
Free Cash Flow per Basic Share	-0.67	-1.55	-2.92	-2.99	-2.21	-2.14	0.08	0.19	0.36	1.84
Cash & Equivalents per Share	1.72	1.4	10.4	4.32	5.23	2.66	2.75	2.95	3.41	5.58
Book Value per Share	-0.8	-2.8	-6.57	-6.59	-8.37	-9.85	-7.09	-6.82	-7.3	-6.23
Tangible Book Value per Share	-0.79	-2.76	9.45	4.17	5.04	2.42	5.45	6.02	5.91	7.44

Kiniksa Pharmaceuticals, Ltd.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)